CAMP4 Therapeutics

company

About

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$100M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
CAMP4 Therapeutics has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Jul 20, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 20, 2022 Series B $100M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
CAMP4 Therapeutics is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series B